Articles Referencing MCI

NASDAQ.com News

Babson Capital Corporate Investors (MCI) Ex-Dividend Date Scheduled for April 25, 2013

Babson Capital Corporate Investors ( MCI ) will begin trading ex-dividend on April 25, 2013. A cash dividend payment of $0.3 per share is scheduled to be paid on May 10, 2013. Shareholders who... Read >>

Zacks.com

Data on Teva's Azilect - Analyst Blog

Teva Pharmaceutical ( TEVA ) and H. Lundbeck A/S recently presented positive data on Azilect from a double-blind, placebo controlled, randomized, multicenter study. Teva and H. Lundbeck... Read >>

Zacks.com

Merck-Luminex' Alzheimer's Collaboration - Analyst Blog

Merck ( MRK ) recently entered into an agreement with Luminex Corporation ( LMNX ) for the development of a companion diagnostic device that will be used to screen patients for... Read >>

Zacks.com

Teva Enrolls First Patient in Study - Analyst Blog

Teva Pharmaceutical Industries Ltd. ( TEVA ) recently announced that it has enrolled the first patient in the phase IV MODERATO ( M ulticenter, Rand o mized, D ouble-Blind,... Read >>

NASDAQ.com News

Babson Capital Corporate Investors (MCI) Ex-Dividend Date Scheduled for December 27, 2012

Babson Capital Corporate Investors ( MCI ) has announced an ex-dividend date of December 27, 2012 and a cash dividend payment of $0.4 per share scheduled for January 11, 2013. Shareholders... Read >>